Author:
Brummelte Susanne,Grund Thorsten,Moll Gunther H,Teuchert-Noodt Gertraud,Dawirs Ralph R
Abstract
Abstract
It is widely believed, that environmental factors play a crucial role in the etiology and outcome of psychiatric diseases such as Attention-Deficit/Hyperactivity Disorder (ADHD). A former study from our laboratory has shown that both methylphenidate (MP) and handling have a positive effect on the dopaminergic fiber density in the prefrontal cortex (PFC) of early traumatized gerbils (Meriones unguiculatus). The current study was performed to investigate if enriched environment during MP application has an additional influence on the dopaminergic and GABAergic fiber densities in the PFC and amygdala in this animal model.
Animals received a single early dose of methamphetamine (MA; 50 mg/kg; i.p.) on postnatal day (PD) 14, which is known to cause multiple changes in the subsequent development of several neurotransmitter systems including the dopaminergic systems, and were then treated with oral daily applications of MP (5 mg/kg) from PD30–60. Animals treated this way were either transferred to an enriched environment after weaning (on PD30) or were kept under impoverished rearing conditions.
There was no effect of an enriched environment on the dopaminergic or GABAergic fiber density neither in the PFC nor in the amygdala. With regard to former studies these results underline the particular impact of MP in the treatment of ADHD.
Publisher
Springer Science and Business Media LLC
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference48 articles.
1. Rothenberger A, Danckaerts M, Dopfner M, Sergeant J, Steinhausen HC: EINAQ -- a European educational initiative on Attention-Deficit Hyperactivity Disorder and associated problems. Eur Child Adolesc Psychiatry. 2004, 13 Suppl 1: I31-I35.
2. Fone KC, Nutt DJ: Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol. 2005, 5: 87-93. 10.1016/j.coph.2004.10.001.
3. Froimowitz M, Patrick KS, Cody V: Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT. Pharm Res. 1995, 12: 1430-1434. 10.1023/A:1016262815984.
4. Gatley SJ, Pan D, Chen R, Chaturvedi G, Ding YS: Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci. 1996, 58: 231-239.
5. Carboni E, Silvagni A: Dopamine reuptake by norepinephrine neurons: exception or rule?. Crit Rev Neurobiol. 2004, 16: 121-128. 10.1615/CritRevNeurobiol.v16.i12.130.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献